Fda Clears Masimos W1 Medical Watch For Connectivity To Its Safetynet Telemonitoring System

Masimo W1 Medical Watch Receives FDA Clearance for Connectivity

Masimo Corp. Announces Clinical Trial Clearance for Innovative Medical Device

FDA 510k Clearance Allows for Integration with Masimo SafetyNet, Enabling Continuous Remote Monitoring

IRVINE, Calif. - August 12, 2024 - Masimo Corp. (NASDAQ: MASI) today announced that the Masimo W1 medical watch has received U.S. Food and Drug Administration (FDA) 510k clearance for connectivity. This clearance allows the Masimo W1 to integrate with Masimo SafetyNet, enabling continuous remote monitoring of vital parameters such as heart rate, oxygen saturation, and respiratory rate.

The Masimo W1 is a wearable medical device designed to provide continuous, real-time monitoring of a patient's vital parameters. The device is equipped with Masimo's Masimo SET Pulse Oximetry technology, which is the most trusted and reliable pulse oximetry technology in the world.

Masimo SafetyNet is a cloud-based platform that collects and stores data from the Masimo W1 and other Masimo medical devices. This data can be accessed by healthcare professionals remotely, allowing them to monitor their patients' vital parameters in real-time.

The combination of the Masimo W1 and Masimo SafetyNet provides healthcare professionals with a powerful tool for monitoring patients both in and out of the hospital. This will enable clinicians to provide timely and accurate care, which will lead to better patient outcomes.

Conclusion: The FDA clearance of the Masimo W1 medical watch for connectivity is a significant milestone in the development of remote patient monitoring. This device will enable healthcare professionals to provide better care for their patients, and will help to improve patient outcomes.